Abstract:Objective:To explore the clinical characteristics, genotypes and long-term outcomes of individuals with 3-methylglutaconic aciduria.Methods:The clinical features, biochemical data, genetic test results and treatment outcomes of six children with 3-methylglutaconic aciduria admitted to the Department of Endocrinology, Genetics and Metabolism, Xinhua Hospital from February 2017 to February 2019 were retrospectively analyzed and the Gesell developmental diagnosis schedule was performed to evaluate the development of four patients.Results:Among 6 children with 3-methylglutaconic aciduria 2 were males and 4 were females.Four cases had 3-methylglutaconic aciduria type Ⅰ and 2 cases had 3-methylglutaconic aciduria with deafness,encephalopathy, and Leigh-like syndrome. Five of 6 patients were detected by newborn screening among whom 4 remained asymptomatic, and only one had a postmortem diagnosis. Among them, 4 patients remained asymptomatic, while two presented with clinical symptoms such as jaundice and dyspnea and the age of disease onset was 1 and 2 days respectively. The concentration of 3-methylglutaconic acid in urine of all affected individuals was between 22.38 and 77.09 mmol/molCr, which was above the normal value. Genetic tests were performed for all patients. Eleven variants were identified in 2 genes, of which 10 variants were novel and only c.442C>T p.(R148X) has been previously reported; Seven variants (c.656-2delA, EX5-EX6 Del, c.942+3A>G, c.373C>T p.(R125W), c.895-3C>G, c.667C>T p.(R223X) and c.894+5G>A) were in AUH gene. The others (c.548G>A p.(R138Q), c.442C>T p.(R148X), c.1339C>T p.(R447X) and c.973dupA p.(M325Nfs*5) were in SERAC1 gene. After being treated with leucine diet restriction and L-carnitine, 4 patients with AUH gene variation who were from asymptomatic phase developed normally, whereas those 2 patients with SERAC1 gene variation had a poor prognosis. During the follow-up, 2 patients exhibited varying degrees of psychomotor retardation, the rest had normal course of development.Conclusions:There are significant clinical heterogeneities among individuals with 3-methylglutaconic aciduria. The most common pathogenic variants are splicing variations, followed by nonsense, missense and frameshift mutations. Leucine-free diet and oral L-carnitine therapy are effective for some patients. Newborn screening is essential for early diagnosis and improvement of prognosis.

Analysis of Clinical Features and the Results of Mass Spectrometry with Glutaric Acidemia Type I

Evaluation of the Clinical, Biochemical, Neurological, and Genetic Presentations of Glutaric Aciduria Type 1 in Patients from China

Clinical and Mutational Spectra of 23 Chinese Patients with Glutaric Aciduria Type 1.

Biochemical and Molecular Features of Chinese Patients with Glutaric Acidemia Type 1 from Fujian Province, Southeastern China

Clinical and Molecular Investigation in Chinese Patients with Glutaric Aciduria Type I

[Clinical and Laboratory Studies on 28 Patients with Glutaric Aciduria Type 1].

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Clinical features and GCDH gene variants in three Chinese families with glutaric aciduria type 1: A case series and literature review

Cranial Magnetic Resonance Imaging in 6 Patients with Glutaric Aciduria Type 1

[Expert Consensus for the Diagnosis and Treatment of Glutaricacidemia Type 1].

Brain Morphometric Analysis in Patients with Glutaric Aciduria Type 1

[Mass Spectrometry Combined with Gene Analysis for Prenatal Diagnosis of Glutaric Acidemia Type Ⅰ].

Comprehensive metabolomics analysis reveals novel biomarkers and pathways in falsely suspected glutaric aciduria Type-1 newborns

Diagnosis of glutaric aciduria type 1 by measuring 3-hydroxyglutaric acid in dried urine spots by liquid chromatography tandem mass spectrometry

Mutation analysis of GCDH gene in eight patients with glutaric aciduria type I]

Prenatal Diagnosis of Glutaric Acidemia I Based on Amniotic Fluid Samples in 42 Families Using Genetic and Biochemical Approaches

[Clinical and Genetic Analysis of an Infant with 3-Methylglutaconic Aciduria Type VII].

Glutaric Aciduria Presenting With an Acute Encephalitic Crisis: A Case Report

Analysis of Six Children with 3-Methylglutaconic Aciduria

An Adult Late-Onset Glutaric Aciduria Type I with Cerebral Infarctions

AB054. Experiences During Newborn Screening for Glutaric Aciduria Type 1: Diagnosis, Treatment, Genotype, Phenotype and Outcomes